Yes the level of GDN involvement is starting to concern me as well. The positive thing is that we appear to have well seasoned CEO. Fingers crossed he comes up with the goods.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%